Disclaimer: This article is for informational purposes only and does not constitute legal, financial, or investment advice. The author is

Introduction Lila Sciences is a cutting-edge startup aiming to revolutionize scientific research through artificial intelligence and automation. Founded in 2023

Anthropic launched "Claude for Life Sciences" in October 2025, introducing new AI capabilities tailored to biotechnology and pharmaceutical

Disclaimer: This article is for informational purposes only and does not constitute legal, financial, or investment advice. The author is

Introduction Royalty deferral structures represent sophisticated financing and licensing arrangements that fundamentally alter the timing and conditionality of royalty payments

Biotech and Pharmaceutical Deals: October 13-19, 2025 The week of October 13-19, 2025 marked one of the most active periods

Royalty financing in biotech and healthcare has exploded into a $5-6 billion annual market in North America, with transactions growing

Background and Evolution Blackstone Life Sciences (BXLS) is the life-sciences investment arm of Blackstone, the world's largest alternative

A delicate French dessert must rise perfectly under precise conditions. In biotechnology, Soufflé Therapeutics — a newly unveiled venture named after

Introduction The Variable Capital Company (VCC) represents a transformative development in Singapore's fund management landscape, particularly for healthcare